This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

"Anti-Aging" Pill Seen In Parade Magazine Creating A Stir Even Before It Hits Newsstand

NEW YORK, Feb. 8, 2013 /PRNewswire/ -- Everybody's talking about human growth hormone (hGH). It's been featured by media giants like The Today Show, Good Morning America, Fox News, CNN, The Dr. Oz Show, Shape magazine and Vanity Fair, and it's rapidly becoming the hottest new "it" treatment among Hollywood A-Listers due to its touted ability to reduce wrinkles, decrease body fat, increase lean muscle mass, boost energy, rev up sex drive, and make you look and feel decades — not years, but DECADES — younger.

But the hGH buzz really exploded last September after a meeting of the prestigious Obesity Society, of all things. At their exclusive 30 th Annual Scientific Meeting, a group of some of the most renowned scientists in the world made a groundbreaking revelation: an oral compound had finally been discovered that was capable of increasing mean hGH levels in the body… by an amazing 682%. The compound is now being sold under the trade name SeroVital™-hgh, and the hype surrounding this revolutionary new product seems to have reached new heights.

It will be seen in an upcoming issue of Parade magazine, and even though it doesn't go on sale until this Sunday's newspapers hit the stands, SeroVital's distributor, SanMedica International™, is already being inundated with inquiries from people who are either extremely excited about this tiny little pill, or who are just curious about all the buzz.

"Quite frankly, we were caught off guard," admits Chantelle Daines, spokesperson for SanMedica. "We expected a big response from the Parade issue, but the fact that it's beginning even before the newspapers hit the stands, while gratifying, really caught us with our pants down, so to speak. We had everybody in the office answering the phones and replying to emails… we couldn't keep up!"

So where is all this interest coming from? "That's what's got us so baffled," says Ms. Daines. "The only people who could have seen the issue are those working for Parade or the press where it's printed, but it's obviously already causing quite a stir. It speaks volumes about America's obsession with human growth hormone and its touted 'anti-aging' benefits!"

SeroVital is the first and only oral compound clinically proven to increase mean, serum (blood) growth hormone levels by 682% in both men and women and across an appropriately wide age range. It's making headlines because up until this point, the best way to increase hGH levels in the human body was through prescription injections. And at a cost of $15,000 or more per year, such injections were available only to the very, very wealthy.

So what's the difference between hGH injections and SeroVital? Because they're synthetic, the injections are extremely controversial — some experts fear that introducing synthetic growth hormone into the body may upset the natural production of hGH. But SeroVital takes a completely different approach. Rather than introducing synthetic hGH into the body, SeroVital raises the body's own, natural levels of human growth hormone by promoting pituitary health, the gland that manufactures hGH. SeroVital has not only made it more affordable for people to raise their hGH levels, but has given them a clinically proven way to raise them naturally.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs